Versant Capital Management’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$54.7K Sell
283
-6
-2% -$741 ﹤0.01% 1342
2026
Q2
$29.7K Buy
289
+2
+0.7% +$130 ﹤0.01% 1721
2026
Q1
$13.6K Buy
287
+181
+171% +$8.12K ﹤0.01% 2000
2025
Q4
$3.36K Hold
106
– – ﹤0.01% 2360
2025
Q3
$2.98K Hold
106
– – ﹤0.01% 2341
2025
Q2
$3.9K Sell
106
-580
-85% -$20K ﹤0.01% 2245
2025
Q1
$26.9K Buy
686
+580
+547% +$26.1K ﹤0.01% 1170
2024
Q4
$4.93K Hold
106
– – ﹤0.01% 1769
2024
Q3
$4.79K Hold
106
– – ﹤0.01% 1309
2024
Q2
$5.22K Hold
106
– – ﹤0.01% 1204
2024
Q1
$3.64K Hold
106
– – ﹤0.01% 1151
2023
Q4
$3.91K Hold
106
– – ﹤0.01% 1055
2023
Q3
$2.15K Hold
106
– – ﹤0.01% 1285
2023
Q2
$2.17K Buy
+106
New +$1.59K ﹤0.01% 1350

Other funds holding TWST

Versant Capital Management's TWST Position: Q3 2026 in Review

Versant Capital Management reduced its Twist Bioscience (TWST) stake by 2.1% in Q3 2026, selling an estimated $741 and leaving 283 shares worth $54.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1342.

Versant Capital Management first reported a position in TWST in Q2 2023 and has held it in 14 quarters since. 431 funds tracked by Wall St. Rank hold TWST as of Q3 2026.

  • Versant Capital Management held 283 shares of Twist Bioscience worth $54.7K as of Q3 2026.
  • Versant Capital Management sold 6 Twist Bioscience shares in Q3 2026, an estimated $741.
  • Twist Bioscience made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #1342 holding.
  • Versant Capital Management first reported a position in Twist Bioscience in Q2 2023 and has held it in 14 quarters since.
  • 431 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.